Hans-Konrad Mueller-Hermelink

This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Patrys Limited. Active years: 2010-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hans-Konrad Mueller-Hermelink. Retrieved from https://idiyas.com/inventor/hans-konrad-mueller-hermelink

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 3 (Patent Applications = 1)

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)

Company Filing History:

3 out of 10

Patrys Limited

patents

Years Active: 2010-2011

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7947812 - Neoplasm specific antibodies and uses thereof (2011-05-24),

2. 7772372 - Neoplasm specific antibodies and uses thereof (2010-08-10),

3. 7741444 - Neoplasm specific antibodies and uses thereof (2010-06-22),

Title: Hans-Konrad Mueller-Hermelink: Innovator in Neoplasm Research

Introduction

Hans-Konrad Mueller-Hermelink is a notable inventor based in Wuerzburg, Germany. He has made significant contributions to the field of medical research, particularly in the development of neoplasm-specific antibodies. With a total of 3 patents to his name, his work has the potential to impact the diagnosis and treatment of various neoplasms.

Latest Patents

One of his latest patents is titled "Neoplasm specific antibodies and uses thereof." This invention features polypeptides, such as antibodies, and their application in the treatment and diagnosis of neoplasms. The innovative approach taken by Mueller-Hermelink in this patent highlights the importance of targeted therapies in modern medicine.

Career Highlights

Hans-Konrad Mueller-Hermelink is associated with Patrys Limited, a company that focuses on developing innovative therapies for cancer treatment. His work at Patrys Limited has allowed him to explore new avenues in antibody research, contributing to advancements in the medical field.

Collaborations

Some of his notable coworkers include Heinz Peter Vollmers and Heinz Vollmers. Their collaboration has likely fostered a productive environment for research and innovation within the company.

Conclusion

Hans-Konrad Mueller-Hermelink's contributions to neoplasm research through his patents and work at Patrys Limited exemplify the vital role of inventors in advancing medical science. His innovative approaches continue to pave the way for new treatments and diagnostic methods.

Profile summary based on public USPTO records.